InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex coronary and vascular diseases. It offers MGuard and MGuard prime embolic protection stents for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions; and CGuard carotid embolic prevention systems for use in carotid artery applications. The company is also developing NVGuard, a neurovascular flow diverter that directs blood flow away from cerebral aneurysms to seal the aneurysms. It operates in the Middle East, Germany, Belarus, Spain, the Russian Federation, and internationally. The company is headquartered in Boston, Massachusetts.
Great earnings report!! Should see a new PT from analyst soon, possibly today. Last PT was set at $3.
